Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GPC2 CAR-T cells |
Synonyms | |
Therapy Description |
GPC2 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) directed against GPC2, which may inhibit growth of GPC2-expressing tumors (PMID: 34971569). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GPC2 CAR-T cells | GPC2 CAR-T cells are T-cells engineered to express a chimeric antigen receptor (CAR) directed against GPC2, which may inhibit growth of GPC2-expressing tumors (PMID: 34971569). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05650749 | Phase I | GPC2 CAR-T cells | GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma (GPC2) | Recruiting | USA | 0 |